1. Home
  2. PETZ vs MBAI Comparison

PETZ vs MBAI Comparison

Compare PETZ & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TDH Holdings Inc.

PETZ

TDH Holdings Inc.

HOLD

Current Price

$1.00

Market Cap

10.0M

Sector

Industrials

ML Signal

HOLD

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.82

Market Cap

10.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PETZ
MBAI
Founded
2002
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Steel/Iron Ore
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
10.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
PETZ
MBAI
Price
$1.00
$1.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.3K
546.9K
Earning Date
11-13-2025
02-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$1,046,006.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.65
$0.56
52 Week High
$1.68
$3.13

Technical Indicators

Market Signals
Indicator
PETZ
MBAI
Relative Strength Index (RSI) 49.09 N/A
Support Level $0.99 N/A
Resistance Level $1.04 N/A
Average True Range (ATR) 0.05 0.00
MACD 0.00 0.00
Stochastic Oscillator 38.77 0.00

Price Performance

Historical Comparison
PETZ
MBAI

About PETZ TDH Holdings Inc.

TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: